MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/2047487318806358

Медицинская библиотека · European journal of preventive cardiology · 2018

The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.

Dalal Hasnain M, Taylor Rod S, Jolly Kate, Davis Russell C, Doherty Patrick, Miles Jackie, van Lingen Robin, Warren Fiona C, Green Colin, Wingham Jennifer, Greaves Colin, Sadler Susannah, Hillsdon Melvyn, Abraham Charles, Britten Nicky, Frost Julia, Singh Sally, Hayward Christopher, Eyre Victoria, Paul Kevin, Lang Chim C, Smith Karen

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cardiac rehabilitation improves health-related quality of life (HRQoL) and reduces hospitalizations in patients with heart failure, but international uptake of cardiac rehabilitation for heart failure remains low.

DESIGN AND

METHODS

The aim of this multicentre randomized trial was to compare the REACH-HF (Rehabilitation EnAblement in CHronicHeart Failure) intervention, a facilitated self-care and home-based cardiac rehabilitation programme to usual care for adults with heart failure with reduced ejection fraction (HFrEF). The study primary hypothesis was that the addition of the REACH-HF intervention to usual care would improve disease-specific HRQoL (Minnesota Living with Heart Failure questionnaire (MLHFQ)) at 12 months compared with usual care alone.

RESULTS

The study recruited 216 participants, predominantly men (78%), with an average age of 70 years and mean left ventricular ejection fraction of 34%. Overall, 185 (86%) participants provided data for the primary outcome. At 12 months, there was a significant and clinically meaningful between-group difference in the MLHFQ score of -5.7 points (95% confidence interval -10.6 to -0.7) in favour of the REACH-HF intervention group ( p = 0.025). With the exception of patient self-care ( p < 0.001) there was no significant difference in other secondary outcomes, including clinical events ( p > 0.05) at follow-up compared with usual care. The mean cost of the REACH-HF intervention was £418 per participant.

CONCLUSIONS

The novel REACH-HF home-based facilitated intervention for HFrEF was clinically superior in disease-specific HRQoL at 12 months and offers an affordable alternative to traditional centre-based programmes to address current low cardiac rehabilitation uptake rates for heart failure.

Для цитирования: Dalal Hasnain M, Taylor Rod S, Jolly Kate, Davis Russell C, Doherty Patrick, Miles Jackie, van Lingen Robin, Warren Fiona C, Green Colin, Wingham Jennifer, Greaves Colin, Sadler Susannah, Hillsdon Melvyn, Abraham Charles, Britten Nicky, Frost Julia, Singh Sally, Hayward Christopher, Eyre Victoria, Paul Kevin, Lang Chim C, Smith Karen. The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.. European journal of preventive cardiology. 2018. DOI: 10.1177/2047487318806358.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.